WashU Medicine was ranked third in the 2025 Thoracic Surgery Foundation’s Top 20 Institutional Honor Roll list.
The Thoracic Surgery Foundation (TSF) has published this list since 1993, recognizing the top research institutions who have received the most cumulative grant funding support from TSF for research and education projects.
Research in cardiothoracic surgery at WashU Medicine focuses on advancing surgical techniques, improving patient outcomes, and exploring innovative therapies for heart and lung diseases. Strong areas of research focus include thoracic immunology, outcomes research, and the development of minimally invasive approaches.
Collaboration between clinical researchers and biomedical engineering experts has led to the creation of cutting-edge technologies, such as tissue engineering and regenerative medicine, offering promising alternatives for damaged heart tissue repair.
Ongoing clinical trials focus on optimizing surgical interventions and exploring the efficacy of new drugs and therapeutic approaches.
“Being ranked in the top three institutions nationwide for TSF funding is a powerful affirmation of Washington University’s commitment to advancing the field of cardiothoracic surgery,” said Tsuyoshi Kaneko, MD, the John M. Shoenberg Chair of Cardiovascular Disease, director of the Division of Cardiothoracic Surgery and chief of the Section of Cardiac Surgery. “This achievement reflects the strength of our teams and reinforces our mission to advance discovery and translate research into improved patient care.”
The foundation is dedicated to improving patient care by investigating in groundbreaking research, embracing innovation, supporting global humanitarian outreach, and promoting excellence in education for cardiothoracic surgeons at all career stages.
The Division of Cardiothoracic Surgery is at the forefront of clinical innovation, powered by cutting-edge technology and dedicated research.